Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Ann Noninvasive Electrocardiol. 2008 Oct;13(4):327–331. doi: 10.1111/j.1542-474X.2008.00250.x

Table 1.

Clinical Characteristics of the LQTS Study Population

Parameters Total Population n=641 No Coronary Disease n=554 Coronary Disease n=87
Female 451 (70) 397 (72) 54 (62)
Age range (yrs) 41–92 41–92 41–83
Mean age at baseline ECG
Baseline QTc findings
  QTc (ms) 489 ± 43 488 ± 43 491 ± 41
  450–499 ms 452 (71) 396 (71) 56 (64)
  ≥500 ms 189 (29) 158 (29) 31 (36)
Syncope before age 40 213 (33) 185 (33) 28 (32)
Genotype positive 282 244 38
  LQT1 135 (48) 120 (50) 15 (39)
  LQT2 128 (46) 107 (44) 21 (55)
  LQT3 19 (7) 17 (7) 2 (5)
Co-morbidity
  Diabetes mellitus 44 (7) 27 (5) 17 (20)
  Hypertension 192 (30) 143 (26) 49 (56)
Cardiac therapy, any time
  Beta-blockers 413 (64) 340 (61) 73 (84)
  Implantable defibrillator 107 (17) 81 (15) 26 (30)
  Pacemaker 59 (9) 47 (8) 12 (14)
  Left sympathetic ganglionectomy 14 (2) 11 (2) 3 (3)
1st diagnosis of coronary disease 87 (14) - 87 (100)
  Angina pectoris 41 (6) - 41 (47)
  Coronary angioplasty 20 (3) - 20 (23)
  Coronary artery bypass surgery 10 (2) - 10 (11)
  Myocardial infarction 16 (2) - 16 (18)
1st LQTS-related cardiac event 98 (15) 83 (15) 15 (17)
  Syncope 88 (14) 76 (14) 12 (14)
  Aborted cardiac arrest 9 (1) 6 (1) 3 (3)
  Sudden cardiac death 1 (0.1) 1 (0.2) 0 (0)

Values in parentheses are percentages.